Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 Minority Interest

Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's minority interest stands at $-360K as of June 2026. That compares with $-360K in the prior-year period — up 0.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 reported $-360K in minority interest versus $-360K a year earlier — essentially flat versus a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $-360K in the prior-year period — up 0.0% year over year. Sustained growth in minority interest can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's minority interest evolved across reporting periods, while the comparison chart places HROWM next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, minority interest is commonly used to spot outliers. Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's reading of $-360K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.